These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16645407)

  • 21. Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.
    Trescher K; Thometich B; Demyanets S; Kassal H; Sedivy R; Bittner R; Holzinger C; Podesser BK
    Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):365-70. PubMed ID: 23656926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester.
    Xu P; Wang YL; Zhu SJ; Luo SY; Piao YS; Zhuang LZ
    Biol Reprod; 2000 Apr; 62(4):988-94. PubMed ID: 10727268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of matrix metalloproteinases 2 and 9 and TGFBR2 gene screening in patients with ascending aortic dilatation.
    Símová J; Skvor J; Reissigová J; Dudra J; Lindner J; Capek P; Zvárová J
    Folia Biol (Praha); 2013; 59(4):154-61. PubMed ID: 24093773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial differences of matrix metalloproteinase-2 and matrix metalloproteinase-9 within abdominal aortic aneurysm wall and intraluminal thrombus.
    Siennicka A; Zuchowski M; Kaczmarczyk M; Cnotliwy M; Clark JS; Jastrzebska M
    J Physiol Pharmacol; 2016 Dec; 67(6):903-910. PubMed ID: 28195071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-β/Smad signaling function in the aortopathies.
    Yuan SM; Wang J; Hu XN; Li DM; Jing H
    Rev Bras Cir Cardiovasc; 2011; 26(3):393-403. PubMed ID: 22086576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies.
    Huang CY; Tseng KC; Lin MN; Tsai JP; Su CC
    J Clin Pathol; 2015 Nov; 68(11):917-22. PubMed ID: 26246386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Results of Thoracic Endovascular Aortic Repair for Type B Aortic Dissection and Risk Factors for Survival.
    Li DL; He YJ; Wang XH; He YY; Wu ZH; Zhu QQ; Shang T; Zhang HK
    J Endovasc Ther; 2020 Jun; 27(3):358-367. PubMed ID: 32166999
    [No Abstract]   [Full Text] [Related]  

  • 30. Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase.
    Kato M; Bai H; Sato K; Kawamoto S; Kaneko M; Ueda T; Kishi D; Ohnishi K
    Circulation; 1995 Nov; 92(9 Suppl):II107-12. PubMed ID: 7586392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection.
    Wen D; Zhou XL; Li JJ; Luo F; Zhang L; Gao LG; Wang LP; Song L; Sun K; Zou YB; Zhang CN; Hui RT
    Clin Chim Acta; 2012 Jan; 413(1-2):198-202. PubMed ID: 22001516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for abdominal aortic aneurysms from a sex perspective.
    Villard C; Wågsäter D; Swedenborg J; Eriksson P; Hultgren R
    Gend Med; 2012 Aug; 9(4):259-266.e2. PubMed ID: 22721599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.
    Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M
    Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of matrix metalloproteinase-9: a possible diagnostic marker of successful endovascular aneurysm repair.
    Hellenthal FA; Ten Bosch JA; Pulinx B; Wodzig WK; de Haan MW; Prins MH; Welten RJ; Teijink JA; Schurink GW
    Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):171-2. PubMed ID: 22172237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
    Hovsepian DM; Ziporin SJ; Sakurai MK; Lee JK; Curci JA; Thompson RW
    J Vasc Interv Radiol; 2000; 11(10):1345-52. PubMed ID: 11099248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
    Montaner J; Alvarez-Sabín J; Molina C; Anglés A; Abilleira S; Arenillas J; González MA; Monasterio J
    Stroke; 2001 Aug; 32(8):1759-66. PubMed ID: 11486102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.